JB Chemicals and Pharmaceuticals’ board will consider the audited financial statement for the year ended March 31, 2017 and also recommendation of dividend for FY17. Besides, the board will consider a proposal for buyback of fully paid-up equity shares of the company.

The price and quantum of shares to be bought back will be keenly observed by investors. Besides, the mode of buyback (tender route or open market buy) will also be eyed.